Valuation : Evogene Ltd.

Market Cap 7.51M 0 6.47M 6.07M 5.54M 10.41M 715M 10.49M 71.94M 27.99M 362M 28.2M 27.58M 1.2B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 7.51M 0 6.47M 6.07M 5.54M 10.41M 715M 10.49M 71.94M 27.99M 362M 28.2M 27.58M 1.2B EV / Sales 2026 *
5.06x
EV / Sales 2027 * 2.89x
Free-Float
72.14%
Yield 2026 *
-
Yield 2027 * -
1 day+0.72%
1 week-3.12%
Current month+7.65%
1 month+7.65%
3 months-15.75%
6 months-35.24%
Current year-44.31%
1 week 158
Extreme 158
172.8
1 month 143.6
Extreme 143.6
229.8
Current year 115.1
Extreme 115.1
410
1 year 115.1
Extreme 115.1
478.7
3 years 115.1
Extreme 115.1
3,700
5 years 115.1
Extreme 115.1
10,430
10 years 115.1
Extreme 115.1
33,500
Manager TitleAgeSince
Chief Executive Officer 60 01/12/2004
Corporate Officer/Principal - -
Corporate Officer/Principal - 01/01/2022
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 03/06/2010
Chairman 60 01/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
11/08/26 Buy

Director

460,000 2.9111%
04/08/26 Buy

Director

800,000 5.0628%
01/04/26 Other

Executive/Senior Manager

20,000 0.2294%
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%-3.12%-60.44%-94.23% 7.51M
-0.45%-2.52%+0.35%+17.20% 49.81B
-1.11%-2.84%+420.04%+505.15% 44.06B
-0.21%+0.37%+36.88%+17.32% 42.99B
-1.95%-3.33%+8.29%+73.25% 40.88B
-0.94%-1.77%+18.34%+46.84% 33.11B
-1.11%-4.20%+25.49%+119.78% 16.58B
+6.10%+4.40% - - 17.27B
-0.14%-2.21%+11.48%+27.90% 14.63B
-1.12%-3.46%+76.50%+39.37% 13.76B
Average -0.02%-1.61%+59.66%+83.62% 27.31B
Weighted average by Cap. -0.45%-1.50%+88.73%+122.50%

Financials

2026 *2027 *
Net sales 1.48M 0 1.28M 1.2M 1.1M 2.06M 141M 2.07M 14.22M 5.53M 71.6M 5.57M 5.45M 237M 2.6M 0 2.24M 2.1M 1.92M 3.6M 247M 3.63M 24.91M 9.69M 125M 9.76M 9.55M 415M
Net income -16.69M -0 -14.37M -13.49M -12.31M -23.13M -1.59B -23.3M -160M -62.2M -805M -62.65M -61.29M -2.67B -13.92M -0 -11.98M -11.25M -10.27M -19.29M -1.32B -19.43M -133M -51.87M -671M -52.25M -51.11M -2.22B
Net Debt - -
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
38
Date Price Change Volume
01/09/26 ILA 167.40 +0.72% 1,994
31/08/26 ILA 166.20 +3.68% 31,324
28/08/26 ILA 160.30 -1.54% 36,058
27/08/26 ILA 162.80 -0.12% 27,700
26/08/26 ILA 163.00 -3.49% 48,194

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVGN Stock